Browsing Category
Pharmatrans Sanaq
The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed…
Paracetamol-loaded tablets were printed by fused deposition modelling technique, using polyvinyl alcohol as a backbone polymer and Affinisol™ HPMC as a plasticizer in all formulations. Four different strategies were applied in order to accelerate the drug release from the tablets. First, different…
Read More...
Read More...
Pharmatrans excipients for improved compactibility and flowability in tablet manufacture
Pharmatrans SANAQ AG specializes in pharmaceutical excipients and active ingredients, harnessing a spirit of innovation and commitment to high quality products based on a solid platform of experience established over almost four decades.
The Pharmatrans SANAQ product portfolio includes a range of…
Read More...
Read More...
Impact of solvents during wet stirred media milling of cross-linked biopolymer suspensions
The aim of this study was to examine the impact of solvents during the wet stirred media milling of cross-linked biopolymers considering breakage kinetics, physical stability of the suspensions, and microhydrodynamics. To this end, a model cross-linked biopolymer, sodium starch glycolate (SSG), was…
Read More...
Read More...
Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for…
Co-processed dry binders for ODTs are important multifunctional excipients for tablet manufacturing by direct compression. Testing their binary mixtures with lubricants is an important aspect of their use in combination with drugs. The aim of this study was to evaluate the rheological and…
Read More...
Read More...
Pharmatrans adds SANAQ® SP205 and SP206 to Direct Compression excipients range
Pharmatrans Sanaq has added SANAQ® SP 205/206 to its DiCom range of Co-Processed Excipients supporting Direct Compression (DC) applications.
DiCom SANAQ® SP205 and SP206 are both based on microcrystalline cellulose (MCC), co-processed with colloidal silicon dioxide (CSD) and Povidone K30…
Read More...
Read More...
Time-controlled release by the incorporation of superdisintegrants within the coat of zein dry…
The aim of this work was to develop zein-based press coated tablets for delayed, time-controlled drug release. Press coated tablets containing dextrates and chlorpheniramine maleate (BCS class 1 drug) in the core, and zein and either NaCl, sodium starch glycolate (SSG) or crospovidone (XPVP) in the…
Read More...
Read More...
Pharmatrans introduces DICOM SANAQ SP204 proprietary excipient with alkaline agent
Pharmatrans Sanaq has now added DICOM SP 204 tailored to help formulation development of moisture sensitive APIs and to stabilize formulations where alkaline conditions need to be controlled to its DICOM SANAQ® range of high functionality co-processed excipients.
SANAQ® SP 204 is a co-processed…
Read More...
Read More...
Pharmatrans SANAQ® SL 004 co-processed Starch/Lactose excipient
Pharmatrans Sanaq now offers SANAQ® SL 004 as a co-processed excipient based on mix 15/85 of maize starch and lactose monohydrate.
SL 004 forms an ultra-uniform and highly compressible lactose excipient for tablet fillings that supports direct compression (DC) applications, aiding tablet…
Read More...
Read More...
DiCOM SANAQ® – a move forward into direct compression
Pharmatrans Sanaq introduces DICOM SANAQ® a range of co-processed excipients with high functionality as an innovative platform for higher quality direct compression (DC) formulations. The webinar will be held November 10, 2020 - 02:00 PM European Time.
Why should attend the webinar and message to…
Read More...
Read More...
Pharmatrans Sugar Spheres SANAQ® USP/Ph.Eur neutral pellets
Pharmatrans Sanaq’s new Sugar Spheres SANAQ® are neutral pellets made of Sucrose and maize starch that meet standards defined in the USP40-NF35, Ph. Eur and JP pharmacopoeia monographies for “Sugar Spheres”.
These white almost spherical cores with slight sweet taste can be used as a neutral basis…
Read More...
Read More...